U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes.
作者信息
Levenson Deborah
出版信息
Am J Med Genet A. 2013 Sep;161A(9):ix-x. doi: 10.1002/ajmg.a.36167.
PMID:23946205
Abstract
摘要
相似文献
1
U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes.
Am J Med Genet A. 2013 Sep;161A(9):ix-x. doi: 10.1002/ajmg.a.36167.
2
Supreme Court ruling broadens BRCA testing options.最高法院裁决扩大了BRCA检测选项。
J Natl Cancer Inst. 2013 Nov 20;105(22):1671-2. doi: 10.1093/jnci/djt342. Epub 2013 Nov 6.
3
Supreme Court rules against gene patents.最高法院对基因专利做出不利裁决。
JAMA. 2013 Jul 24;310(4):357-9. doi: 10.1001/jama.2013.8627.
4
Sequenom, the U.S. Supreme Court, and Personalized Medicine.Sequenom公司、美国最高法院与个性化医疗
Hum Gene Ther Clin Dev. 2016 Jun;27(2):49-52. doi: 10.1089/humc.2016.29012.kod. Epub 2016 Jun 6.
5
Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.最高法院将就乳腺癌1号基因（BRAC1）和乳腺癌2号基因（BRAC2）的专利是否有效做出裁决。
BMJ. 2012 Dec 5;345:e8266. doi: 10.1136/bmj.e8266.
6
Gene patenting--the Supreme Court finally speaks.基因专利——最高法院终于表态了。
N Engl J Med. 2013 Aug 29;369(9):869-75. doi: 10.1056/NEJMhle1308199. Epub 2013 Jul 10.
7
8
[U.S. Supreme Court ruling on patentability of genes].[美国最高法院关于基因可专利性的裁决]
Rev Derecho Genoma Hum. 2013 Jul-Dec(39):99-118.
9
[The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].[最高法院的自由基因——经济和法律依据——对创新及医疗服务的影响]
Med Sci (Paris). 2015 Feb;31(2):209-13. doi: 10.1051/medsci/20153102019. Epub 2015 Mar 4.
10
US personalized-medicine industry takes hit from Supreme Court.美国个性化医疗行业受到最高法院的打击。
Nature. 2016 Aug 25;536(7617):382. doi: 10.1038/nature.2016.20436.
引用本文的文献
1
Laboratory business models and practices: implications for availability and access to germline genetic testing.实验室商业模式和实践：对种系遗传检测的可及性和可获得性的影响。
Genet Med. 2021 Sep;23(9):1681-1688. doi: 10.1038/s41436-021-01184-z. Epub 2021 May 6.
Zotero 插件